EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Ruthenium(II)–Arene Complexes with a 2,2′-Bipyridine Ligand as Anti-Aβ Agents

Ryan M Hacker, Jacob J Smith, David C Platt, William W Brennessel iD, Marjorie A Jones iD, Michael I Webb iD

Biomolecules · 2025

DOI: 10.3390/biom15040475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Ryan M Hacker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, SUNY Geneseo, Geneseo, NY 14454, USA. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, 2,2'-Dipyridyl, Ruthenium, Coordination Complexes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Agents that target the amyloid-β (Aβ) peptide associated with Alzheimer’s disease have seen renewed interest following the clinical success of antibody therapeutics. Small molecules, specifically metal-based complexes, are excellent candidates for advancement, given their relative ease of preparation and modular scaffold. Herein, several ruthenium–arene complexes containing 2,2-bipyridine (bpy) ligands were prepared and evaluated for their respective ability to modulate the aggregation of Aβ. This was carried out using the three sequential methods of thioflavin T (ThT) fluorescence, dynamic ligand scattering (DLS), and transmission electron microscopy (TEM). Overall, it was observed that RuBA, the complex with a 4,4-diamino-2,2-bipyridine ligand, had the greatest impact on Aβ aggregation. Further evaluation of the complexes was performed to determine their relative affinity for serum albumin and biocompatibility towards two neuronal cell lines. Ultimately, RuBA outperformed the other Ru complexes, where the structure–activity relationship codified the importance of the amino groups on the bpy for anti-Aβ activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-Peptides2,2'-DipyridylRutheniumCoordination ComplexesHumansLigandsAlzheimer DiseaseProtein Aggregates

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloid-βhuman serum albuminruthenium therapeutics

Substanzen

Amyloid beta-Peptides2,2'-DipyridylRutheniumLigandsCoordination ComplexesProtein Aggregates

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, SUNY Geneseo, Geneseo, NY 14454, USA.
  • Department of Chemistry, Illinois State University, Normal, IL 69701, USA.
  • Department of Chemistry, University of Rochester, Rochester, NY 14627, USA.

ORCID-Profile: William W Brennessel, Marjorie A Jones, Michael I Webb

Zitieren

APA

Hacker, R. M., Smith, J. J., Platt, D. C., Brennessel, W. W., Jones, M. A., & Webb, M. I. (2025). Ruthenium(II)–Arene Complexes with a 2,2′-Bipyridine Ligand as Anti-Aβ Agents. Biomolecules. https://doi.org/10.3390/biom15040475

Vancouver

Hacker RM, Smith JJ, Platt DC, Brennessel WW, Jones MA, Webb MI. Ruthenium(II)–Arene Complexes with a 2,2′-Bipyridine Ligand as Anti-Aβ Agents. Biomolecules. 2025. doi:10.3390/biom15040475

BibTeX
@article{Hacker2025,
  author = {Hacker, Ryan M and Smith, Jacob J and Platt, David C and Brennessel, William W and Jones, Marjorie A and Webb, Michael I},
  title = {Ruthenium(II)–Arene Complexes with a 2,2′-Bipyridine Ligand as Anti-Aβ Agents},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15040475}
}
Kostenlos starten →